Advertisement

Topics

Dr. Reddy’s Laboratories Launches Aspirin and Extended-Release Dipyridamole Capsules in the U.S. Market

11:33 EST 24 Dec 2018 | Investing News Network

Dr. Reddy’s Laboratories (BSE:500124,NSE:DRREDDY,NYSE:RDY), along with its subsidiaries together referred to as “Dr. Reddy’s”, today announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) Capsules in the United States market from the U.S. Food and Drug Administration (USFDA). As quoted in the press release: … Continued

The post Dr. Reddy’s Laboratories Launches Aspirin and Extended-Release Dipyridamole Capsules in the U.S. Market appeared first on Investing News Network.

Original Article: Dr. Reddy’s Laboratories Launches Aspirin and Extended-Release Dipyridamole Capsules in the U.S. Market

NEXT ARTICLE

More From BioPortfolio on "Dr. Reddy’s Laboratories Launches Aspirin and Extended-Release Dipyridamole Capsules in the U.S. Market"

Advertisement
Quick Search
Advertisement
Advertisement